https://www.nasdaq.com/press-release/applied-molecular-transport-to-present-at-virtual-jefferies-london-healthcare
https://www.nasdaq.com/press-release/applied-molecular-transport-reports-third-quarter-2021-financial-results-and-provides
https://www.nasdaq.com/press-release/applied-molecular-transport-to-host-virtual-research-development-day-on-october-15
https://www.nasdaq.com/press-release/applied-molecular-transport-announces-upcoming-investor-events-in-september-and
https://www.nasdaq.com/press-release/applied-molecular-transport-appoints-holly-schachner-m.d.-to-its-board-of-directors
https://www.nasdaq.com/press-release/applied-molecular-transport-reports-second-quarter-2021-financial-results-and
https://www.nasdaq.com/press-release/applied-molecular-transport-to-present-at-canaccord-genuitys-41st-annual-growth
https://www.nasdaq.com/press-release/applied-molecular-transport-presents-additional-positive-data-from-oral-amt-101-phase
https://www.nasdaq.com/press-release/applied-molecular-transport-to-present-at-jmp-securities-life-sciences-conference
https://www.nasdaq.com/press-release/applied-molecular-transport-to-present-at-jefferies-virtual-healthcare-conference
https://www.nasdaq.com/press-release/applied-molecular-transport-reports-first-quarter-2021-financial-results-and-provides
https://www.nasdaq.com/press-release/applied-molecular-transport-to-present-at-bofa-securities-2021-health-care-conference
https://www.nasdaq.com/press-release/applied-molecular-transport-announces-closing-of-public-offering-and-full-exercise-of
https://www.nasdaq.com/press-release/applied-molecular-transport-announces-pricing-of-public-offering-of-common-stock-2021
https://www.nasdaq.com/press-release/applied-molecular-transport-announces-proposed-public-offering-of-common-stock-2021
https://www.nasdaq.com/press-release/applied-molecular-transport-appoints-earl-douglas-as-general-counsel-2021-03-22
https://www.nasdaq.com/press-release/applied-molecular-transport-reports-fourth-quarter-and-full-year-2020-financial
https://www.nasdaq.com/press-release/applied-molecular-transport-to-present-at-oppenheimer-31st-annual-healthcare
https://www.nasdaq.com/press-release/applied-molecular-transport-expands-clinical-pipeline-and-announces-first-subject
https://www.nasdaq.com/press-release/applied-molecular-transport-to-present-at-svb-leerink-10th-annual-global-healthcare
https://www.nasdaq.com/press-release/applied-molecular-transport-appoints-douglas-rich-as-chief-technical-officer-2021-01
https://www.nasdaq.com/press-release/applied-molecular-transport-to-present-at-evercore-isi-3rd-annual-healthconx
https://www.nasdaq.com/press-release/applied-molecular-transport-reports-third-quarter-2020-financial-results-and-provides
https://www.nasdaq.com/press-release/applied-molecular-transport-to-present-at-jefferies-virtual-london-healthcare
https://www.nasdaq.com/press-release/applied-molecular-transport-announces-publication-of-preclinical-data-demonstrating
https://www.nasdaq.com/press-release/applied-molecular-transport-to-present-at-jefferies-next-generation-ibd-therapeutics
https://www.nasdaq.com/press-release/applied-molecular-transport-announces-first-patient-dosed-in-phase-2-study-of-oral
https://www.nasdaq.com/press-release/applied-molecular-transport-reports-second-quarter-2020-financial-results-2020-08-11
